BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 26, 2026
Home
»
Newsletters
» BioWorld
BioWorld
June 4, 2010
View Archived Issues
Molecular Reasons Behind Tamiflu Resistance Found
Read More
RetroVirox Building Antiviral Candidates for Others to Grow
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More
Arena Raising $35.5M in Stock Sale to Deerfield as PDUFA Date Looms
Arena Pharmaceuticals Inc. has agreed to sell shares to Deerfield Management for $35.5 million, money that will bolster the biotech's cash as it seeks FDA approval of its obesity compound lorcaserin. (BioWorld Today)
Read More
Tioga Seeking to Change D-IBS Landscape with PIII Under Way
Read More
